Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 33,889 | 24,957 | 19,064 | 23,979 | 32,811 |
| Cost of Goods | 3,647 | 3,712 | 3,267 | 3,576 | 4,215 |
| Gross Profit | 30,242 | 21,245 | 15,797 | 20,403 | 28,596 |
| Operating Expenses | 177,608 | 170,190 | 173,231 | 182,872 | 170,674 |
| Operating Income | -146,719 | -148,233 | -157,167 | -161,893 | -141,863 |
| Interest Expense | 4,562 | 1,927 | 3,325 | 3,378 | 3,912 |
| Other Income | -7,363 | 595 | -10,805 | 2,599 | 3,443 |
| Pre-tax Income | -158,644 | -149,565 | -171,297 | -162,672 | -142,332 |
| Net Income Continuous | -158,644 | -149,565 | -171,297 | -162,672 | -142,332 |
| Net Income | $-158,644 | $-149,565 | $-171,297 | $-162,672 | $-142,332 |
| EPS Basic Total Ops | -0.84 | -0.84 | -0.99 | -1.04 | -0.96 |
| EPS Basic Continuous Ops | -0.83 | -0.84 | -0.99 | -1.04 | -0.97 |
| EPS Diluted Total Ops | -0.84 | -0.84 | -0.99 | -1.04 | -0.96 |
| EPS Diluted Continuous Ops | -0.83 | -0.84 | -0.99 | -1.04 | -0.97 |
| EBITDA(a) | $-138,336 | $-141,418 | $-149,422 | $-154,729 | $-133,288 |